Retour
Également cotée sous
SDMHF
OTC
Fourchette du Jour
18,88 €
20,08 €
Fourchette 52 Semaines
17,40 €
26,54 €
Volume
144
Moyenne 50J / 200J
22,02 €
/
22,46 €
Clôture Précédente
19,46 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 765,7 | 0,3 |
| P/B | 47,8 | 3,0 |
| ROE % | 6,3 | 3,7 |
| Net Margin % | 9,0 | 3,8 |
| Rev Growth 5Y % | -0,3 | 10,0 |
| D/E | 0,7 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2027 |
0,00 €
0,00 € – 0,00 €
|
3,05B | 0 |
| FY2026 |
0,00 €
0,00 € – 0,00 €
|
2,75B | 0 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-12-31 | N/A | 0,00 € | — |
| 2025-10-16 | N/A | 0,01 € | — |
| 2025-07-22 | N/A | 0,08 € | — |
| 2025-04-16 | N/A | 0,10 € | — |
| 2025-01-28 | N/A | 0,05 € | — |
| 2024-10-17 | N/A | 0,03 € | — |
| 2024-07-18 | N/A | 0,05 € | — |
| 2024-04-18 | N/A | 0,06 € | — |
Dividend History
Yield
0,00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue declined -0,32% annually over 5 years
Earnings grew 45,70% over the past year
Generating 139,66M in free cash flow
P/E of 765,74 — premium valuation
Croissance
Revenue Growth (5Y)
-0,32%
Revenue (1Y)2,53%
Earnings (1Y)45,70%
FCF Growth (3Y)-28,45%
Qualité
Return on Equity
6,32%
ROIC5,78%
Net Margin8,95%
Op. Margin18,50%
Sécurité
Debt / Equity
0,67
Current Ratio1,02
Interest Coverage3,60
Valorisation
P/E Ratio
765,74
Forward P/EN/A
P/B Ratio47,78
EV/EBITDA374,86
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2,53% | Revenue Growth (3Y) | 1,34% |
| Earnings Growth (1Y) | 45,70% | Earnings Growth (3Y) | -9,24% |
| Revenue Growth (5Y) | -0,32% | Earnings Growth (5Y) | -11,42% |
| Profitability | |||
| Revenue (TTM) | 2,85B | Net Income (TTM) | 255,12M |
| ROE | 6,32% | ROA | 3,18% |
| Gross Margin | 45,33% | Operating Margin | 18,50% |
| Net Margin | 8,95% | Free Cash Flow (TTM) | 139,66M |
| ROIC | 5,78% | FCF Growth (3Y) | -28,45% |
| Safety | |||
| Debt / Equity | 0,67 | Current Ratio | 1,02 |
| Interest Coverage | 3,60 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 765,74 | Forward P/E | N/A |
| P/B Ratio | 47,78 | P/S Ratio | 68,54 |
| PEG Ratio | -9,01 | Forward PEG | N/A |
| EV/EBITDA | 374,86 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 0,07% | ||
| Market Cap | 195,35B | Enterprise Value | 197,68B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,85B | 2,78B | 2,78B | 3,49B | 2,89B |
| Net Income | 255,12M | 175,10M | 309,70M | 876,10M | 414,40M |
| EPS (Diluted) | 0,03 | 0,18 | 0,34 | 0,95 | 0,45 |
| Gross Profit | 1,29B | 1,21B | 1,23B | 1,82B | 1,55B |
| Operating Income | 527,33M | 370,60M | 484,50M | 1,08B | 683,30M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 8,01B | 8,26B | 7,74B | 5,07B | 3,95B |
| Total Liabilities | 3,89B | 4,23B | 5,07B | 2,55B | 2,22B |
| Shareholders' Equity | 4,09B | 3,99B | 2,64B | 2,45B | 1,66B |
| Total Debt | 2,75B | 2,87B | 3,68B | 1,14B | 625,52M |
| Cash & Equivalents | 425,92M | 678,90M | 116,60M | 107,10M | 223,63M |
| Current Assets | 1,44B | 1,74B | 1,42B | 1,67B | 1,46B |
| Current Liabilities | 1,41B | 938,80M | 937,30M | 1,04B | 1,04B |